ENvue Medical (FEED) Other financing activities (2015 - 2024)
ENvue Medical's (FEED) quarterly Other financing activities came in at -$27000.0 in Q3 2024, down 485.71% quarter-over-quarter from $7000.0 in Q1 2023.
Powered by 
Analysis
ENvue Medical (FEED) Other financing activities (2015 - 2024) Analysis & Trends
ENvue Medical (FEED) has reported Other financing activities for 6 consecutive years, with -$27000.0 the latest figure, recorded in Q3 2024.
- On a quarterly basis, Other financing activities changed N/A year-over-year to -$27000.0 in Q3 2024; TTM through Dec 2025 was -$27000.0, a 0.0% change from a year earlier, with the FY2025 full-year figure at $102000.0, up 10100.0% from the prior year.
- Other financing activities was -$27000.0 for Q3 2024 at ENvue Medical, down from $7000.0 in the prior quarter.
- Over five years, Other financing activities peaked at $3.6 million in Q3 2021 and troughed at -$27000.0 in Q3 2024.
- A 3-year average of $1.2 million and a median of $706500.0 in 2021 frame the typical range for Other financing activities.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn |
| 10 | ENvue Medical | 1.83 Mn | 685,650.21 | -266,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | -27,000.00 |
| Mar 31, 2023 | 7,000.00 |
| Sep 30, 2021 | 3.60 Mn |
| Mar 31, 2021 | 1.41 Mn |
| Dec 31, 2019 | 62,000.00 |
| Jun 30, 2019 | -3.20 Mn |
| Dec 31, 2018 | 47,000.00 |
| Mar 31, 2015 | 446,000.00 |